Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
10.50
-0.42 (-3.85%)
At close: Jul 17, 2026, 4:00 PM EDT
10.71
+0.21 (2.00%)
After-hours: Jul 17, 2026, 5:09 PM EDT
Silence Therapeutics Employees
Silence Therapeutics had 88 employees as of December 31, 2025. The number of employees decreased by 28 or -24.14% compared to the previous year.
Employees
88
Change (1Y)
-28
Growth (1Y)
-24.14%
Revenue / Employee
$9,534
Profits / Employee
-$852,716
Market Cap
495.96M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 88 | -28 | -24.14% |
| Dec 31, 2024 | 116 | 7 | 6.42% |
| Dec 31, 2023 | 109 | -13 | -10.66% |
| Dec 31, 2022 | 122 | 17 | 16.19% |
| Dec 31, 2021 | 105 | 40 | 61.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| Arvinas | 246 |
| ProKidney | 231 |
| Verastem | 102 |
| Assembly Biosciences | 73 |
| Altimmune | 57 |
| Crescent Biopharma | 55 |
| Contineum Therapeutics | 51 |
SLN News
- 4 days ago - Silence Therapeutics participates in a conference call with Cantor - TheFly
- 4 days ago - Silence Therapeutics participates in a conference call with William Blair - TheFly
- 25 days ago - Cantor starts ‘materially undervalued’ Silence Therapeutics at Overweight - TheFly
- 25 days ago - Silence Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 26 days ago - Silence Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Silence Therapeutics highlights follow-up data on divesiran at EHA 2026 - TheFly
- 5 weeks ago - Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera - Business Wire
- 6 weeks ago - Silence Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts